Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

15.80 +0.46 (+3.00%)
Streaming Delayed Price Updated: 1:55 PM EDT, Apr 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
7 Ways to Prepare for a Recession: An Investor’s Guide ↗
There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next. 
Via InvestorPlace
News headline image
IPO Market Posts Slowest Quarter Since Great Recession ↗
IPOs in the second quarter plunged to the lowest level since the Great Recession in 2009, led by health care and technology. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022 ↗
Upgrades 
Via Benzinga
News headline image
2 Cheap Stocks Trading at “Deal of the Century” Prices ↗
Simple value metrics are provenly bad at generating consistent returns, but that doesn't mean there aren't opportunities to be found. 
Via InvestorPlace
News headline image
Expert Ratings for Bausch & Lomb ↗
Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
3 Value Stocks That Could 2x in a Recession ↗
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022 ↗
Upgrades 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More ↗
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO ↗
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022. 
Via InvestorPlace
News headline image
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow ↗
RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous $816... 
Via Benzinga
News headline image
Opening Day: Bausch + Lomb Pops In Public Debut ↗
Shares of Bausch + Lomb rose over 11% to end its first trading day at $20. This was the second biggest IPO of the year. Bausch + Lomb opened at $18.50 after having priced its initial public offering at... 
Via Talk Markets
News headline image
BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today ↗
Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.